Dual Functional Radioactive Gel‐Microspheres for Combinatorial Radioembolization and Photothermal Therapy of Hepatocellular Carcinoma
Advanced Healthcare Materials · 2025
DOI: 10.1002/adhm.202401057 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2025. Verfasst von Jing Sun und 10 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Radiation Medicine and Protection, School of Radiation Medicine and Protection, Collaborative Innovation Center of Radiation …. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Microspheres, Liver Neoplasms, Photothermal Therapy. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: National Natural Science Found of China, Interdisciplinary Basic Frontier Innovation Program of Suzhou Medical College of Soochow University, State Key Laboratory of Radiation Medicine and Protection.
Abstract (Originalsprache)
Transarterial radioembolization (TARE) is an established clinical therapy for treating patients with intermediate to advanced hepatocellular carcinoma (HCC) or those who cannot undergo radical treatment. However, the delivery of a high radiation dose is associated with several adverse effects, such as radiation pneumonitis. Additionally, the available radioactive microspheres (MSs) are dense and unsuitable for interventional delivery. This study proposes the use of commercial CalliSpheres polyvinyl alcohol (PVA) gel MSs coated with polydopamine (PDA) as a carrier for radioactive iodine ( 131 I) labeled using the iodogen method, denoted as 131 I‐PDA@PVA MSs, which can be for radioembolization combined photothermal therapy (PTT) of HCC. In vitro experiments have demonstrated that 131 I‐PDA@PVA MSs have high radiolabeling stability and photothermal properties. Single photon emission computed tomography (SPECT)/computed tomography (CT) imaging and biodistribution experiments have shown that 131 I‐PDA@PVA MSs remain stable in vivo without any radioactive leakage. The results of the antitumor study suggest that 131 I‐PDA@PVA MSs are an effective treatment for inhibiting tumor growth through a combination of radioembolization and PTT while avoiding significant side effects. These multifunctional MSs have great potential for clinical application in the treatment of HCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Radiation Medicine and Protection, School of Radiation Medicine and Protection, Collaborative Innovation Center of Radiation Medicine of Jiangsu Higher Education Institutions, Soochow University,…
- Department of Interventional, The Second Affiliated Hospital of Soochow University, Suzhou, 215006, P. R. China.
- Suzhou Hengrui Medical Devices Co., Ltd, Suzhou, 215127, P. R. China.
- Experimental Center of Soochow University, Department of Medicine, Soochow University, Suzhou, 215123, P. R. China.
ORCID-Profile: Guanglin Wang
Förderung
- National Natural Science Found of China
- Interdisciplinary Basic Frontier Innovation Program of Suzhou Medical College of Soochow University
- State Key Laboratory of Radiation Medicine and Protection
Zitieren
APA
Sun, J., Sun, X., Yin, L., Jin, S., Huang, Q., Dong, Y., Gu, X., Zhang, Y., Jin, Y., Zhu, R., & Wang, G. (2025). Dual Functional Radioactive Gel‐Microspheres for Combinatorial Radioembolization and Photothermal Therapy of Hepatocellular Carcinoma. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202401057
Vancouver
Sun J, Sun X, Yin L, Jin S, Huang Q, Dong Y, et al. Dual Functional Radioactive Gel‐Microspheres for Combinatorial Radioembolization and Photothermal Therapy of Hepatocellular Carcinoma. Advanced Healthcare Materials. 2025. doi:10.1002/adhm.202401057
BibTeX
@article{Sun2025,
author = {Sun, Jing and Sun, Xingwei and Yin, Liang and Jin, Shuo and Huang, Qian and Dong, Yi and Gu, Xiaolei and Zhang, Yujuan and Jin, Yong and Zhu, Ran and Wang, Guanglin},
title = {Dual Functional Radioactive Gel‐Microspheres for Combinatorial Radioembolization and Photothermal Therapy of Hepatocellular Carcinoma},
journal = {Advanced Healthcare Materials},
year = {2025},
doi = {10.1002/adhm.202401057}
}
EUVIMED